Blood Pressure Medication Recalled Due to Packaging Flaw
The MHRA has issued a precautionary recall for a popular blood pressure medication after discovering a packaging error. Pharmacies and healthcare providers must return all remaining stock.
The United Kingdom's Medicines and Healthcare products Regulatory Agency (MHRA) has advised pharmacy and healthcare professionals to return all remaining stock of a popular blood pressure medication to their suppliers. This precautionary recall comes after the agency discovered a packaging error that could potentially lead to medication mix-ups.
The affected product is Ramipril 1.25mg capsules, which are commonly prescribed to treat high blood pressure and other cardiovascular conditions. The packaging issue involves the incorrect labeling of some blister packs, potentially causing patients to receive the wrong dosage strength.
{{IMAGE_PLACEHOLDER}}Source: UK Government
